Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DY268 is a compound based on trisubstituted pyrazolamide without any FXR agonist activity and cytotoxicity and can be used as an effective FXR antagonist (IC50 = 7.5 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 34.00 | |
5 mg | In stock | $ 80.00 | |
10 mg | In stock | $ 128.00 | |
25 mg | In stock | $ 258.00 | |
50 mg | In stock | $ 478.00 | |
100 mg | In stock | $ 689.00 | |
500 mg | In stock | $ 1,480.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 89.00 |
Description | DY268 is a compound based on trisubstituted pyrazolamide without any FXR agonist activity and cytotoxicity and can be used as an effective FXR antagonist (IC50 = 7.5 nM). |
Targets&IC50 | FXR:7.5 nM |
Synonyms | DY 268, DY-268 |
Molecular Weight | 560.66 |
Formula | C30H32N4O5S |
CAS No. | 1609564-75-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (89.18 mM)
H2O: Insoluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DY268 1609564-75-1 Metabolism FXR NR1H4 DY 268 DY-268 inhibit Inhibitor inhibitor